Gyre Therapeutics Inc. (GYRE) — Free Cash Flow Generation Index
Gyre Therapeutics Inc. (GYRE) has a Free Cash Flow Generation Index of 0.94x as of March 2026. Free cash flow of $3.00 Million represents 1% of operating cash flow ($3.18 Million). Read Gyre Therapeutics Inc. debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Gyre Therapeutics Inc. Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Gyre Therapeutics Inc. across 5 annual periods. Explore how much does Gyre Therapeutics Inc. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Gyre Therapeutics Inc. (2007–2025)
Year-by-year Free Cash Flow Generation Index for Gyre Therapeutics Inc.. For the full company profile including market capitalisation, see Gyre Therapeutics Inc. (GYRE) market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.18x | $-180.00K | $1.01 Million | $1.19 Million | ▼ -126.7% |
| 2023 | 0.67x | $17.31 Million | $25.89 Million | $8.59 Million | ▲ +25.7% |
| 2022 | 0.53x | $5.68 Million | $10.68 Million | $5.00 Million | ▼ -45.5% |
| 2010 | 0.98x | $134.99 Million | $138.30 Million | $3.31 Million | ▲ +21.9% |
| 2007 | 0.80x | $19.89 Million | $24.84 Million | $4.94 Million | — |